2016Mucosal immunology9 (2) : 428-43
Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths
Smith K, Filbey K, Reynolds L, Hewitson J, Harcus Y, Boon L, Sparwasser T, Hämmerling G, Maizels R
2016Scientific reports6 : 22212
Functional modules of sigma factor regulons guarantee adaptability and evolvability
Binder S, Eckweiler D, Schulz S, Bielecka A, Nicolai T, Franke R, Häussler S, Meyer-Hermann M
2016BMC infectious diseases16 : 77
Development and virucidal activity of a novel alcohol-based hand disinfectant supplemented with urea and citric acid
Ionidis G, Hübscher J, Jack T, Becker B, Bischoff B, Todt D, Hodasa V, Brill F, Steinmann E, Steinmann J
2016PloS one11 (1) : e0147811
RNASeq Based Transcriptional Profiling of Pseudomonas aeruginosa PA14 after Short- and Long-Term Anoxic Cultivation in Synthetic Cystic Fibrosis Sputum Medium
Tata M, Wolfinger M, Amman F, Roschanski N, Dötsch A, Sonnleitner E, Häussler S, Bläsi U
2016Scientific reports6 : 20134
Topical imiquimod yields systemic effects due to unintended oral uptake
Grine L, Steeland S, Van Ryckeghem S, Ballegeer M, Lienenklaus S, Weiss S, Sanders N, Vandenbroucke R, Libert C
2016Journal of neuroinflammation13 : 22
Type I Interferon response in olfactory bulb, the site of tick-borne flavivirus accumulation, is primarily regulated by IPS-1
Kurhade C, Zegenhagen L, Weber E, Nair S, Michaelsen-Preusse K, Spanier J, Gekara N, Kröger A, Överby A
2016Current topics in microbiology and immunology398 : 55-87
Epidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community
Mehraj J, Witte W, Akmatov M, Layer F, Werner G, Krause G
2016Veterinary microbiology182 : 8-14
Frequent presence of hepaci and pegiviruses in commercial equine serum pools
Postel A, Cavalleri J, Pfaender S, Walter S, Steinmann E, Fischer N, Feige K, Haas L, Becher P
2016Clinical and experimental rheumatology34 (3) : 548-53
Real-life practice of methotrexate toxicity monitoring in juvenile idiopathic arthritis in Germany, Switzerland and Austria: results of a cross-sectional assessment conducted in 2012
Akmatov M, Stumme M, Pessler F
2016Hepatology (Baltimore, Md.)63 (1) : 49-62
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Perin P, Haid S, Brown R, Doerrbecker J, Schulze K, Zeilinger C, von Schaewen M, Heller B, Vercauteren K, Luxenburger E, Baktash Y, Vondran F, Speerstra S, Awadh A, Mukhtarov F, Schang L, Kirschning A, Müller R, Guzman C, Kaderali L, Randall G, Meuleman P, Ploss A, Pietschmann T
